Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Monash IVF to acquire 80% of Perth fertility clinic for $12m in expansion bid
    • News

    Monash IVF to acquire 80% of Perth fertility clinic for $12m in expansion bid

    Fertility specialists Monash IVF (ASX: MVF) appears to have found fertile ground for growth, as it locks in the acquisition of Perth-based IVF and fertility clinic Fertility North. Fertility North services Perth’s northern suburbs, helping MVF attract new clientele. Monash IVF will acquire 80% of Fertility North through an initial upfront cash payment estimated at

    Read More
    Public
  • First time in 25 years, Tissue Repair set to introduce drug for Venous Leg Ulcers, wins US patent for compound
    • News

    First time in 25 years, Tissue Repair set to introduce drug for Venous Leg Ulcers, wins US patent for compound

    The US Patent and Trademark Office (USPTO) has recently approved the third patent application submitted by the biotech company Tissue Repair (ASX: TRP), which focuses on developing wound-healing agents. This patent—titled “BIOLOGICAL POLYSACCHARIDE COMPOUND” ]—includes claims that extend to the Glucoprime® compound and its molecule, allowing for various applications.  Glucoprime and its derivatives serve as

    Read More
    Public
  • G8 Education issues 69% profit growth guidance, driven by managing educator wages
    • News

    G8 Education issues 69% profit growth guidance, driven by managing educator wages

    With the largest workforce of early childhood educators in the country, G8 Education (ASX: GEM) has long struggled to manage their wage bill while delivering maximum profit for shareholders. That looks to have changed in 2023 though, with the Company divesting unprofitable centres and streamlining their workforce, in lieu of occupancy growth.  The Company announced

    Read More
    Public
  • Grind higher continues
    • Market Update

    Grind higher continues

    The XJO is expected to edge higher on open this morning following renewed buying in the U.S overnight. Their futures are flat. Yesterday we managed to crawl back most our opening losses to finish marginally flat. We were likely driven by positive U.S futures that moved higher through our session, heralding the renewed buying we

    Read More
    Public
  • After TGA and Chairman fiasco, Rhythm Biosciences concedes no commercial sales are possible for its bowel cancer kits
    • News

    After TGA and Chairman fiasco, Rhythm Biosciences concedes no commercial sales are possible for its bowel cancer kits

    Medical diagnostics company Rhythm Biosciences (ASX: RHY) has undertaken a comprehensive strategic review following major shareholder discontent and a subsequent S249D notice requesting a vote to remove the Chairman. In October, the Company faced regulatory scrutiny as its stock value plunged from 32¢ to 20¢, triggering an ASX “speeding ticket”. Later, the stock was trading

    Read More
    Public
  • Black Friday gives Bedshed a much-needed boost after prior lull, acquires new stores
    • News

    Black Friday gives Bedshed a much-needed boost after prior lull, acquires new stores

    Kitchen, wardrobe and other household products supplier Joyce Corporation (ASX: JYC) has announced the expansion of its bedding subsidiary, Bedshed, with the acquisition of two prime locations in suburban Sydney. The franchise agreements, finalised with two franchisees, will see Bedshed taking control of stores in Alexandria and Castle Hill. The move is part of Bedshed’s

    Read More
    Public
  • «
  • ‹
  • 137
  • 138
  • 139
  • 140
  • 141
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.